Abiraterone
The serum concentration of Quinine can be increased when it is combined with Abiraterone.
Acarbose
Acarbose may increase the hypoglycemic activities of Quinine.
Acebutolol
Quinine may increase the hypotensive activities of Acebutolol.
Advertisement
Aceclofenac
The metabolism of Aceclofenac can be decreased when combined with Quinine.
Acenocoumarol
Quinine may increase the anticoagulant activities of Acenocoumarol.
Acepromazine
The serum concentration of Acepromazine can be increased when it is combined with Quinine.
Advertisement
Aceprometazine
The serum concentration of Aceprometazine can be increased when it is combined with Quinine.
Acetaminophen
The metabolism of Acetaminophen can be decreased when combined with Quinine.
Acetohexamide
Acetohexamide may increase the hypoglycemic activities of Quinine.
Advertisement
Acetyl salicylate
The metabolism of Acetylsalicylic acid can be decreased when combined with Quinine.
Acetyl Sulfisoxazole
The metabolism of Quinine can be decreased when combined with Acetyl sulfisoxazole.
Acetylcholine
The metabolism of Acetylcholine can be decreased when combined with Quinine.
Acetylcholine Chloride
The metabolism of Acetylcholine can be decreased when combined with Quinine.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Quinine.
Ajmaline
The metabolism of Ajmaline can be decreased when combined with Quinine.
Albuterol
Salbutamol may increase the QTc-prolonging activities of Quinine.
Alfuzosin
Alfuzosin may increase the QTc-prolonging activities of Quinine.
Aliskiren
Quinine may increase the hypotensive activities of Aliskiren.
Almotriptan
The metabolism of Almotriptan can be decreased when combined with Quinine.
Alogliptin
The metabolism of Alogliptin can be decreased when combined with Quinine.
Aloglutamol
The serum concentration of Quinine can be decreased when it is combined with Aloglutamol.
Alosetron
The metabolism of Alosetron can be decreased when combined with Quinine.
Aloxiprin
Aloxiprin may increase the hypoglycemic activities of Quinine.
Alprazolam
The metabolism of Alprazolam can be decreased when combined with Quinine.
Alprenolol
The metabolism of Alprenolol can be decreased when combined with Quinine.
Aluminum
The serum concentration of Quinine can be decreased when it is combined with Aluminium.
Aluminum Hydroxide
The serum concentration of Quinine can be decreased when it is combined with Aluminum hydroxide.
aluminum hydroxide, dried (USP)
The serum concentration of Quinine can be decreased when it is combined with Aluminum hydroxide.
Aluminum Magnesium Silicate
The serum concentration of Quinine can be decreased when it is combined with Almasilate.
Amantadine
Amantadine may increase the QTc-prolonging activities of Quinine.
Ambrisentan
Quinine may increase the hypotensive activities of Ambrisentan.
AMBROXOL ACEFYLLINATE
The serum concentration of Ambroxol acefyllinate can be increased when it is combined with Quinine.
Ambroxol-Theophylline-7-Acetate
The serum concentration of Ambroxol acefyllinate can be increased when it is combined with Quinine.
Aminophylline
The serum concentration of Aminophylline can be increased when it is combined with Quinine.
Aminopyrine
The metabolism of Aminophenazone can be decreased when combined with Quinine.
Aminosalicylic Acid
Aminosalicylic Acid may increase the hypoglycemic activities of Quinine.
Amiodarone
The risk or severity of QTc prolongation can be increased when Quinine is combined with Amiodarone.
Amitriptyline
Amitriptyline may increase the QTc-prolonging activities of Quinine.
Amlodipine
Quinine may increase the hypotensive activities of Amlodipine.
Amodiaquine
The serum concentration of Amodiaquine can be increased when it is combined with Quinine.
Amoxapine
Amoxapine may increase the QTc-prolonging activities of Quinine.
Amphetamine
The metabolism of Amphetamine can be decreased when combined with Quinine.
Amprenavir
The metabolism of Amprenavir can be decreased when combined with Quinine.
Amsacrine
The metabolism of Amsacrine can be decreased when combined with Quinine.
Anagrelide
The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Quinine.
Antipyrine
The metabolism of Antipyrine can be decreased when combined with Quinine.
Apalutamide
The serum concentration of Quinine can be decreased when it is combined with Apalutamide.
Apixaban
The metabolism of Apixaban can be decreased when combined with Quinine.
Apomorphine
Apomorphine may increase the QTc-prolonging activities of Quinine.
Aprepitant
The serum concentration of Quinine can be increased when it is combined with Aprepitant.
Aprindine
The metabolism of Aprindine can be decreased when combined with Quinine.
Arachidonic Acid
The metabolism of Arachidonic Acid can be decreased when combined with Quinine.
Arformoterol
Arformoterol may increase the QTc-prolonging activities of Quinine.
Aripiprazole
The serum concentration of Aripiprazole can be decreased when it is combined with Quinine.
Armodafinil
The metabolism of Quinine can be decreased when combined with Armodafinil.
Arsenic Trioxide
The risk or severity of QTc prolongation can be increased when Quinine is combined with Arsenic trioxide.
Artemether
The risk or severity of QTc prolongation can be increased when Quinine is combined with Artemether.
Asenapine
The risk or severity of QTc prolongation can be increased when Quinine is combined with Asenapine.
Aspirin
The metabolism of Acetylsalicylic acid can be decreased when combined with Quinine.
Astemizole
The metabolism of Astemizole can be decreased when combined with Quinine.
Asunaprevir
The serum concentration of Asunaprevir can be decreased when it is combined with Quinine.
Atazanavir
The metabolism of Quinine can be decreased when combined with Atazanavir.
Atenolol
Quinine may increase the hypotensive activities of Atenolol.
Atomoxetine
Atomoxetine may increase the QTc-prolonging activities of Quinine.
Atorvastatin
The risk or severity of renal failure and rhabdomyolysis can be increased when Quinine is combined with Atorvastatin.
Atracurium
Quinine may increase the neuromuscular blocking activities of Atracurium.
Atracurium Besylate
Quinine may increase the neuromuscular blocking activities of Atracurium besylate.
Avatrombopag
The metabolism of Avatrombopag can be decreased when combined with Quinine.
Azelastine
The metabolism of Azelastine can be decreased when combined with Quinine.
Azithromycin
The serum concentration of Quinine can be increased when it is combined with Azithromycin.
Balsalazide
Balsalazide may increase the hypoglycemic activities of Quinine.
Bedaquiline
Bedaquiline may increase the QTc-prolonging activities of Quinine.
Benazepril
Quinine may increase the hypotensive activities of Benazepril.
Bendroflumethiazide
Quinine may increase the hypotensive activities of Bendroflumethiazide.
Benztropine
The metabolism of Benzatropine can be decreased when combined with Quinine.
Benzyl Alcohol
The metabolism of Benzyl alcohol can be decreased when combined with Quinine.
Bepridil
The metabolism of Bepridil can be decreased when combined with Quinine.
Betaxolol
The metabolism of Betaxolol can be decreased when combined with Quinine.
Bethanidine
Quinine may increase the hypotensive activities of Bethanidine.
Bexarotene
The metabolism of Bexarotene can be decreased when combined with Quinine.
Bimatoprost
Quinine may increase the hypotensive activities of Bimatoprost.
Bioallethrin
The metabolism of Bioallethrin can be decreased when combined with Quinine.
Bismuth Subcitrate
The serum concentration of Quinine can be decreased when it is combined with Bismuth Subcitrate.
Bismuth Subnitrate
The serum concentration of Quinine can be decreased when it is combined with Bismuth subnitrate.
Bisoprolol
The metabolism of Bisoprolol can be decreased when combined with Quinine.
Boceprevir
The metabolism of Quinine can be decreased when combined with Boceprevir.
Bortezomib
Bortezomib may increase the QTc-prolonging activities of Quinine.
Bosentan
The serum concentration of Bosentan can be increased when it is combined with Quinine.
Bosentan Anhydrous
The serum concentration of Bosentan can be increased when it is combined with Quinine.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Quinine.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Quinine.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Quinine.
Bretylium
Quinine may increase the hypotensive activities of Bretylium.
Brexpiprazole
The serum concentration of Brexpiprazole can be increased when it is combined with Quinine.
Brigatinib
The metabolism of Brigatinib can be decreased when combined with Quinine.
Brimonidine
Quinine may increase the hypotensive activities of Brimonidine.
Brivaracetam
The metabolism of Brivaracetam can be decreased when combined with Quinine.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Quinine.
Brompheniramine
The metabolism of Brompheniramine can be decreased when combined with Quinine.
Bupivacaine
The metabolism of Bupivacaine can be decreased when combined with Quinine.
Bupranolol
Quinine may increase the hypotensive activities of Bupranolol.
Buprenorphine
The metabolism of Buprenorphine can be decreased when combined with Quinine.
Bupropion
The metabolism of Quinine can be decreased when combined with Bupropion.
Buserelin
Buserelin may increase the QTc-prolonging activities of Quinine.
Buspirone
The metabolism of Buspirone can be decreased when combined with Quinine.
Cabazitaxel
The metabolism of Cabazitaxel can be decreased when combined with Quinine.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Quinine.
Cabozantinib
The metabolism of Cabozantinib can be decreased when combined with Quinine.
Cafedrine
Quinine may increase the hypotensive activities of Cafedrine.
Caffeine
The metabolism of Quinine can be decreased when combined with Caffeine.
Calcium Carbonate
The serum concentration of Quinine can be decreased when it is combined with Calcium Carbonate.
CALCIUM CARBONATE, PRECIPITATED
The serum concentration of Quinine can be decreased when it is combined with Calcium Carbonate.
Canagliflozin
Canagliflozin may increase the hypoglycemic activities of Quinine.
Canagliflozin Anhydrous
Canagliflozin may increase the hypoglycemic activities of Quinine.
Candesartan
The metabolism of Candesartan can be decreased when combined with Quinine.
Candesartan Cilexetil
The metabolism of Candesartan cilexetil can be decreased when combined with Quinine.
Cannabidiol
The metabolism of Cannabidiol can be decreased when combined with Quinine.
Cannavis sativa susp. indica top extract
The metabolism of Medical Cannabis can be decreased when combined with Quinine.
Capecitabine
The metabolism of Quinine can be decreased when combined with Capecitabine.
Captopril
The metabolism of Captopril can be decreased when combined with Quinine.
Carbamazepine
The serum concentration of Quinine can be decreased when it is combined with Carbamazepine.
Carbinoxamine
The metabolism of Carbinoxamine can be decreased when combined with Quinine.
Cariprazine
The metabolism of Cariprazine can be decreased when combined with Quinine.
Carteolol
The metabolism of Carteolol can be decreased when combined with Quinine.
Carvedilol
The serum concentration of Carvedilol can be increased when it is combined with Quinine.
Celecoxib
The metabolism of Quinine can be decreased when combined with Celecoxib.
Celiprolol
Quinine may increase the hypotensive activities of Celiprolol.
Cephalexin
The metabolism of Cephalexin can be decreased when combined with Quinine.
CEPHALEXIN ANHYDROUS
The metabolism of Cephalexin can be decreased when combined with Quinine.
Ceritinib
The serum concentration of Quinine can be increased when it is combined with Ceritinib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Quinine.
Cevimeline
The metabolism of Cevimeline can be decreased when combined with Quinine.
Chloramphenicol
The metabolism of Quinine can be decreased when combined with Chloramphenicol.
Chlordiazepoxide
The metabolism of Chlordiazepoxide can be decreased when combined with Quinine.
Chloroquine
Chloroquine may increase the QTc-prolonging activities of Quinine.
Chlorothiazide
Quinine may increase the hypotensive activities of Chlorothiazide.
Chlorpheniramine
The metabolism of Chlorphenamine can be decreased when combined with Quinine.
CHLORPHENIRAMINE POLISTIREX
The metabolism of Chlorphenamine can be decreased when combined with Quinine.
Chlorpromazine
Chlorpromazine may increase the QTc-prolonging activities of Quinine.
Chlorpropamide
The metabolism of Chlorpropamide can be decreased when combined with Quinine.
Chlorthalidone
Quinine may increase the hypotensive activities of Chlorthalidone.
Chlorzoxazone
The metabolism of Chlorzoxazone can be decreased when combined with Quinine.
Cholecalciferol
The metabolism of Quinine can be decreased when combined with Cholecalciferol.
Cicletanine
Quinine may increase the hypotensive activities of Cicletanine.
Cilazapril
Quinine may increase the hypotensive activities of Cilazapril.
Cilostazol
The serum concentration of Cilostazol can be increased when it is combined with Quinine.
Cimetidine
The serum concentration of Quinine can be increased when it is combined with Cimetidine.
Cinacalcet
The metabolism of Quinine can be decreased when combined with Cinacalcet.
Cinnarizine
The metabolism of Cinnarizine can be decreased when combined with Quinine.
Cinoxacin
Cinoxacin may increase the hypoglycemic activities of Quinine.
Ciprofloxacin
Ciprofloxacin may increase the QTc-prolonging activities of Quinine.
Cisapride
The risk or severity of QTc prolongation can be increased when Quinine is combined with Cisapride.
Cisatracurium
Quinine may increase the neuromuscular blocking activities of Cisatracurium.
Citalopram
The risk or severity of QTc prolongation can be increased when Citalopram is combined with Quinine.
Clarithromycin
The serum concentration of Quinine can be increased when it is combined with Clarithromycin.
Clemastine
The metabolism of Quinine can be decreased when combined with Clemastine.
Clevidipine
The metabolism of Clevidipine can be decreased when combined with Quinine.
Clevidipine butyrate
The metabolism of Clevidipine can be decreased when combined with Quinine.
Clobazam
The metabolism of Quinine can be decreased when combined with Clobazam.
Clofezone
The metabolism of Quinine can be decreased when combined with Rabeprazole.
Clomipramine
Clomipramine may increase the QTc-prolonging activities of Quinine.
Clonidine
The metabolism of Clonidine can be decreased when combined with Quinine.
Clopidogrel
The metabolism of Clopidogrel can be decreased when combined with Quinine.
Clotrimazole
The metabolism of Quinine can be decreased when combined with Clotrimazole.
Clozapine
Clozapine may increase the QTc-prolonging activities of Quinine.
Cobicistat
The serum concentration of Quinine can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Quinine can be decreased when combined with Cocaine.
Codeine
The therapeutic efficacy of Codeine can be decreased when used in combination with Quinine.
Codeine Anhydrous
The therapeutic efficacy of Codeine can be decreased when used in combination with Quinine.
CODEINE POLISTIREX
The therapeutic efficacy of Codeine can be decreased when used in combination with Quinine.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Quinine.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Quinine.
Crisaborole
The metabolism of Quinine can be decreased when combined with Crisaborole.
Crizotinib
Crizotinib may increase the QTc-prolonging activities of Quinine.
Cryptenamine
Quinine may increase the hypotensive activities of Cryptenamine.
Curcumin
The metabolism of Quinine can be decreased when combined with Curcumin.
Cyclobenzaprine
The metabolism of Cyclobenzaprine can be decreased when combined with Quinine.
Cyclopenthiazide
Quinine may increase the hypotensive activities of Cyclopenthiazide.
Cyclophosphamide
The metabolism of Cyclophosphamide can be decreased when combined with Quinine.
Cyclophosphamide Anhydrous
The metabolism of Cyclophosphamide can be decreased when combined with Quinine.
Cyclosporine
The metabolism of Quinine can be decreased when combined with Cyclosporine.
Cyclothiazide
Quinine may increase the hypotensive activities of Cyclothiazide.
Cyproterone Acetate
The serum concentration of Quinine can be decreased when it is combined with Cyproterone acetate.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Quinine.
Dabrafenib
The serum concentration of Quinine can be decreased when it is combined with Dabrafenib.
Dapagliflozin
The metabolism of Dapagliflozin can be decreased when combined with Quinine.
Dapsone
The risk or severity of adverse effects can be increased when Quinine is combined with Dapsone.
Darifenacin
The metabolism of Quinine can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Quinine can be increased when it is combined with Darunavir.
Dasabuvir
The metabolism of Dasabuvir can be decreased when combined with Quinine.
Dasatinib
The serum concentration of Quinine can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Quinine can be increased when it is combined with Dasatinib.
Debrisoquin
The metabolism of Debrisoquin can be decreased when combined with Quinine.
Deferasirox
The serum concentration of Quinine can be decreased when it is combined with Deferasirox.
Degarelix
Degarelix may increase the QTc-prolonging activities of Quinine.
Delavirdine
The metabolism of Quinine can be decreased when combined with Delavirdine.
Deserpidine
Quinine may increase the hypotensive activities of Deserpidine.
Desflurane
Desflurane may increase the QTc-prolonging activities of Quinine.
Desipramine
Desipramine may increase the QTc-prolonging activities of Quinine.
Desvenlafaxine
Desvenlafaxine may increase the hypoglycemic activities of Quinine.
Deutetrabenazine
The metabolism of Deutetrabenazine can be decreased when combined with Quinine.
Dexchlorpheniramine maleate
The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Quinine.
Dexfenfluramine
The metabolism of Dexfenfluramine can be decreased when combined with Quinine.
Dexmethylphenidate
The metabolism of Dexmethylphenidate can be decreased when combined with Quinine.
Dextroamphetamine
The metabolism of Dextroamphetamine can be decreased when combined with Quinine.
Dextromethorphan
The metabolism of Dextromethorphan can be decreased when combined with Quinine.
Diazepam
The metabolism of Diazepam can be decreased when combined with Quinine.
Diazoxide
Quinine may increase the hypotensive activities of Diazoxide.
Diclofenac
The metabolism of Diclofenac can be decreased when combined with Quinine.
Dicumarol
Quinine may increase the anticoagulant activities of Dicoumarol.
Diflunisal
Diflunisal may increase the hypoglycemic activities of Quinine.
Digoxin
The serum concentration of Digoxin can be increased when it is combined with Quinine.
Dihydralazine
Quinine may increase the hypotensive activities of Dihydralazine.
Dihydrocodeine
The metabolism of Dihydrocodeine can be decreased when combined with Quinine.
Dihydroergocornine
The risk or severity of adverse effects can be increased when Dihydroergocornine is combined with Quinine.
Dihydroergocristine
The risk or severity of adverse effects can be increased when Dihydroergocristine is combined with Quinine.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Quinine.
Diltiazem
The metabolism of Quinine can be decreased when combined with Diltiazem.
Diphenhydramine
Diphenhydramine may increase the QTc-prolonging activities of Quinine.
Disopyramide
The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Quinine.
Doconexent
The metabolism of Doconexent can be decreased when combined with Quinine.
Dofetilide
The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Quinine.
Dolasetron
Dolasetron may increase the QTc-prolonging activities of Quinine.
Domperidone
The risk or severity of QTc prolongation can be increased when Quinine is combined with Domperidone.
Donepezil
The metabolism of Donepezil can be decreased when combined with Quinine.
Dopamine
The metabolism of Dopamine can be decreased when combined with Quinine.
Dorzolamide
The metabolism of Dorzolamide can be decreased when combined with Quinine.
Dothiepin
The metabolism of Quinine can be decreased when combined with Dosulepin.
Doxacurium Chloride
Quinine may increase the neuromuscular blocking activities of Doxacurium chloride.
Doxazosin
The metabolism of Doxazosin can be decreased when combined with Quinine.
Doxepin
Doxepin may increase the QTc-prolonging activities of Quinine.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Quinine.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Quinine.
Doxycycline
The metabolism of Quinine can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Quinine can be decreased when combined with Doxycycline.
Dronedarone
The risk or severity of QTc prolongation can be increased when Quinine is combined with Dronedarone.
Droperidol
Droperidol may increase the QTc-prolonging activities of Quinine.
Dulaglutide
Dulaglutide may increase the hypoglycemic activities of Quinine.
Duloxetine
The metabolism of Quinine can be decreased when combined with Duloxetine.
Dyphylline
The serum concentration of Dyphylline can be increased when it is combined with Quinine.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Quinine.
Efavirenz
The metabolism of Quinine can be decreased when combined with Efavirenz.
Eletriptan
The metabolism of Eletriptan can be decreased when combined with Quinine.
Eliglustat
The serum concentration of Eliglustat can be increased when it is combined with Quinine.
Eltrombopag
The metabolism of Eltrombopag can be decreased when combined with Quinine.
Empagliflozin
Empagliflozin may increase the hypoglycemic activities of Quinine.
Enalapril
Quinine may increase the hypotensive activities of Enalapril.
Enalaprilat
Quinine may increase the hypotensive activities of Enalaprilat.
Enalaprilat Anhydrous
Quinine may increase the hypotensive activities of Enalaprilat.
Enasidenib
The metabolism of Enasidenib can be decreased when combined with Quinine.
Encainide
The metabolism of Encainide can be decreased when combined with Quinine.
Enoxacin
Enoxacin may increase the hypoglycemic activities of Quinine.
Enzalutamide
The serum concentration of Quinine can be decreased when it is combined with Enzalutamide.
Epinastine
The metabolism of Epinastine can be decreased when combined with Quinine.
Epoprostenol
The metabolism of Epoprostenol can be decreased when combined with Quinine.
Eprosartan
Quinine may increase the hypotensive activities of Eprosartan.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Quinine.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Quinine.
Eribulin
Eribulin may increase the QTc-prolonging activities of Quinine.
Erlotinib
The metabolism of Erlotinib can be decreased when combined with Quinine.
Erythromycin
The serum concentration of Quinine can be increased when it is combined with Erythromycin.
Escitalopram
The risk or severity of QTc prolongation can be increased when Quinine is combined with Escitalopram.
Eslicarbazepine Acetate
The metabolism of Quinine can be decreased when combined with Eslicarbazepine acetate.
Esomeprazole
The metabolism of Quinine can be decreased when combined with Esomeprazole.
Estradiol
The metabolism of Estradiol can be decreased when combined with Quinine.
Estradiol 3-Benzoate
The metabolism of Estradiol benzoate can be decreased when combined with Quinine.
Estradiol acetate
The metabolism of Estradiol acetate can be decreased when combined with Quinine.
Estradiol Cypionate
The metabolism of Estradiol cypionate can be decreased when combined with Quinine.
Estradiol Valerate
The metabolism of Estradiol valerate can be decreased when combined with Quinine.
Estrone
The metabolism of Estrone can be decreased when combined with Quinine.
Eszopiclone
The metabolism of Eszopiclone can be decreased when combined with Quinine.
Ethylmorphine
The metabolism of Ethylmorphine can be decreased when combined with Quinine.
Etodolac
The metabolism of Etodolac can be decreased when combined with Quinine.
Etoricoxib
The metabolism of Etoricoxib can be decreased when combined with Quinine.
Etravirine
The metabolism of Quinine can be decreased when combined with Etravirine.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Quinine.
Exenatide
Exenatide may increase the hypoglycemic activities of Quinine.
Ezogabine
Ezogabine may increase the QTc-prolonging activities of Quinine.
Famotidine
Famotidine may increase the QTc-prolonging activities of Quinine.
Felbamate
Felbamate may increase the QTc-prolonging activities of Quinine.
Felodipine
The metabolism of Quinine can be decreased when combined with Felodipine.
Fenoldopam
Quinine may increase the hypotensive activities of Fenoldopam.
Ferulic Acid
Quinine may increase the hypotensive activities of Ferulic acid.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Quinine.
Fingolimod
Fingolimod may increase the QTc-prolonging activities of Quinine.
Flecainide
Flecainide may increase the QTc-prolonging activities of Quinine.
Fleroxacin
Fleroxacin may increase the hypoglycemic activities of Quinine.
Floxuridine
The metabolism of Quinine can be decreased when combined with Floxuridine.
Fluconazole
The metabolism of Quinine can be decreased when combined with Fluconazole.
Fluindione
Quinine may increase the anticoagulant activities of Fluindione.
Flumequine
Flumequine may increase the hypoglycemic activities of Quinine.
Flunarizine
The metabolism of Flunarizine can be decreased when combined with Quinine.
Flunitrazepam
The metabolism of Flunitrazepam can be decreased when combined with Quinine.
Fluorouracil
The metabolism of Quinine can be decreased when combined with Fluorouracil.
Fluoxetine
The risk or severity of QTc prolongation can be increased when Quinine is combined with Fluoxetine.
Fluoxymesterone
Fluoxymesterone may increase the hypoglycemic activities of Quinine.
Flupenthixol
The risk or severity of QTc prolongation can be increased when Quinine is combined with Flupentixol.
Fluphenazine
The serum concentration of Fluphenazine can be increased when it is combined with Quinine.
Flurbiprofen
The metabolism of Flurbiprofen can be decreased when combined with Quinine.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Quinine.
Fluvoxamine
The metabolism of Quinine can be decreased when combined with Fluvoxamine.
Formoterol
Formoterol may increase the QTc-prolonging activities of Quinine.
Fosamprenavir
The metabolism of Quinine can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Quinine can be increased when it is combined with Fosaprepitant.
Foscarnet
Foscarnet may increase the QTc-prolonging activities of Quinine.
Fosinopril
Quinine may increase the hypotensive activities of Fosinopril.
Fosphenytoin
The serum concentration of Quinine can be decreased when it is combined with Fosphenytoin.
Furazolidone
Furazolidone may increase the hypoglycemic activities of Quinine.
Fusidate
The serum concentration of Quinine can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Quinine can be increased when it is combined with Fusidic Acid.
Gadobenate
Gadobenic acid may increase the QTc-prolonging activities of Quinine.
Galantamine
Galantamine may increase the QTc-prolonging activities of Quinine.
Gallamine Triethiodide
Quinine may increase the neuromuscular blocking activities of Gallamine Triethiodide.
Gatifloxacin
Gatifloxacin may increase the hypoglycemic activities of Quinine.
Gatifloxacin Anhydrous
Gatifloxacin may increase the hypoglycemic activities of Quinine.
Gefitinib
The metabolism of Gefitinib can be decreased when combined with Quinine.
Gemfibrozil
The metabolism of Quinine can be decreased when combined with Gemfibrozil.
Gemifloxacin
Gemifloxacin may increase the QTc-prolonging activities of Quinine.
Gemifloxacin Mesylate
Gemifloxacin may increase the QTc-prolonging activities of Quinine.
Glibornuride
Glibornuride may increase the hypoglycemic activities of Quinine.
Gliclazide
The metabolism of Gliclazide can be decreased when combined with Quinine.
Glimepiride
The metabolism of Glimepiride can be decreased when combined with Quinine.
Glipizide
The metabolism of Glipizide can be decreased when combined with Quinine.
Gliquidone
Gliquidone may increase the hypoglycemic activities of Quinine.
Glyburide
The metabolism of Glyburide can be decreased when combined with Quinine.
Goserelin
Goserelin may increase the QTc-prolonging activities of Quinine.
Granisetron
Granisetron may increase the QTc-prolonging activities of Quinine.
Grepafloxacin
Grepafloxacin may increase the hypoglycemic activities of Quinine.
Guanabenz
Quinine may increase the hypotensive activities of Guanabenz.
Guanadrel
Quinine may increase the hypotensive activities of Guanadrel.
Guanethidine
Quinine may increase the hypotensive activities of Guanethidine.
Guanfacine
The metabolism of Guanfacine can be decreased when combined with Quinine.
Halofantrine
The risk or severity of adverse effects can be increased when Quinine is combined with Halofantrine.
Haloperidol
Haloperidol may increase the QTc-prolonging activities of Quinine.
Halothane
The metabolism of Halothane can be decreased when combined with Quinine.
Hexobarbital
The metabolism of Hexobarbital can be decreased when combined with Quinine.
Histamine
The metabolism of Histamine can be decreased when combined with Quinine.
Histrelin
Histrelin may increase the QTc-prolonging activities of Quinine.
Hydralazine
Quinine may increase the hypotensive activities of Hydralazine.
Hydrochlorothiazide
Quinine may increase the hypotensive activities of Hydrochlorothiazide.
Hydrocodone
The metabolism of Hydrocodone can be decreased when combined with Quinine.
HYDROCODONE POLISTIREX
The metabolism of Hydrocodone can be decreased when combined with Quinine.
Hydroflumethiazide
Quinine may increase the hypotensive activities of Hydroflumethiazide.
Hydromorphone
The metabolism of Hydromorphone can be decreased when combined with Quinine.
Hydrotalcite
The serum concentration of Quinine can be decreased when it is combined with Hydrotalcite.
Hydroxyzine
Hydroxyzine may increase the QTc-prolonging activities of Quinine.
Hypoxis hemerocallidea root extract
The serum concentration of Quinine can be decreased when it is combined with St. John's Wort.
Ibandronate
Ibandronate may increase the QTc-prolonging activities of Quinine.
Ibandronic Acid
Ibandronate may increase the QTc-prolonging activities of Quinine.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Quinine.
Ibuprofen
The metabolism of Ibuprofen can be decreased when combined with Quinine.
Ibutilide
The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Quinine.
Idarubicin
The metabolism of Idarubicin can be decreased when combined with Quinine.
Idelalisib
The metabolism of Quinine can be decreased when combined with Idelalisib.
Ifosfamide
The metabolism of Ifosfamide can be decreased when combined with Quinine.
Iloperidone
The risk or severity of QTc prolongation can be increased when Quinine is combined with Iloperidone.
Imatinib
The metabolism of Quinine can be decreased when combined with Imatinib.
Imidapril
Quinine may increase the hypotensive activities of Imidapril.
Imipramine
Imipramine may increase the QTc-prolonging activities of Quinine.
Indacaterol
Indacaterol may increase the QTc-prolonging activities of Quinine.
Indapamide
Indapamide may increase the QTc-prolonging activities of Quinine.
Indinavir
The metabolism of Quinine can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Quinine can be decreased when combined with Indinavir.
Indomethacin
The metabolism of Indomethacin can be decreased when combined with Quinine.
Indoramin
Quinine may increase the hypotensive activities of Indoramin.
Insulin Detemir
Quinine may increase the hypoglycemic activities of Insulin Detemir.
Insulin Glargine
Insulin Glargine may increase the hypoglycemic activities of Quinine.
insulin human, rDNA origin
Insulin Human may increase the hypoglycemic activities of Quinine.
Insulin Lispro
Insulin Lispro may increase the hypoglycemic activities of Quinine.
Insulin, Aspart Protamine, Human
Quinine may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Aspart, Human
Quinine may increase the hypoglycemic activities of Insulin Aspart.
Insulin, Glulisine, Human
Quinine may increase the hypoglycemic activities of Insulin Glulisine.
Insulin, Pork
Insulin Pork may increase the hypoglycemic activities of Quinine.
Insulin, Protamine Lispro, Human
Insulin Lispro may increase the hypoglycemic activities of Quinine.
Insulin, Regular, Pork
Insulin Pork may increase the hypoglycemic activities of Quinine.
Ipecac
The metabolism of Ipecac can be decreased when combined with Quinine.
Ipratropium
The metabolism of Ipratropium bromide can be decreased when combined with Quinine.
Ipratropium cation
The metabolism of Ipratropium bromide can be decreased when combined with Quinine.
Iproniazid
Iproniazid may increase the hypoglycemic activities of Quinine.
Irbesartan
The metabolism of Quinine can be decreased when combined with Irbesartan.
Isavuconazole
The serum concentration of Quinine can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Quinine can be decreased when combined with Isavuconazonium.
Isocarboxazid
Isocarboxazid may increase the hypoglycemic activities of Quinine.
Isoflurane
Isoflurane may increase the QTc-prolonging activities of Quinine.
Isoniazid
The metabolism of Quinine can be decreased when combined with Isoniazid.
Isradipine
Isradipine may increase the QTc-prolonging activities of Quinine.
Itraconazole
The metabolism of Quinine can be decreased when combined with Itraconazole.
Ivabradine
Quinine may increase the QTc-prolonging activities of Ivabradine.
Ivacaftor
The serum concentration of Quinine can be increased when it is combined with Ivacaftor.
Ixazomib
The metabolism of Ixazomib can be decreased when combined with Quinine.
Josamycin
The serum concentration of Quinine can be increased when it is combined with Josamycin.
Ketamine
The metabolism of Ketamine can be decreased when combined with Quinine.
Ketanserin
Quinine may increase the hypotensive activities of Ketanserin.
Ketoconazole
The metabolism of Quinine can be decreased when combined with Ketoconazole.
Ketoprofen
The metabolism of Ketoprofen can be decreased when combined with Quinine.
Labetalol
The metabolism of Labetalol can be decreased when combined with Quinine.
Lacidipine
Quinine may increase the hypotensive activities of Lacidipine.
Lanreotide
Quinine may increase the hypoglycemic activities of Lanreotide.
Lansoprazole
The metabolism of Lansoprazole can be decreased when combined with Quinine.
Lapatinib
Lapatinib may increase the QTc-prolonging activities of Quinine.
Latanoprost
Quinine may increase the hypotensive activities of Latanoprost.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Quinine.
Leflunomide
The metabolism of Leflunomide can be decreased when combined with Quinine.
Lenvatinib
Lenvatinib may increase the QTc-prolonging activities of Quinine.
Lenvatinib Mesylate
Lenvatinib may increase the QTc-prolonging activities of Quinine.
Lercanidipine
Quinine may increase the hypotensive activities of Lercanidipine.
Lesinurad
The metabolism of Lesinurad can be decreased when combined with Quinine.
Letermovir
The metabolism of Letermovir can be decreased when combined with Quinine.
Leuprolide
Leuprolide may increase the QTc-prolonging activities of Quinine.
Levodopa
The metabolism of Levodopa can be decreased when combined with Quinine.
Levofloxacin
Levofloxacin may increase the QTc-prolonging activities of Quinine.
Levofloxacin Anhydrous
Levofloxacin may increase the QTc-prolonging activities of Quinine.
Levomilnacipran
The metabolism of Levomilnacipran can be decreased when combined with Quinine.
Lidocaine
The metabolism of Quinine can be decreased when combined with Lidocaine.
Linagliptin
Linagliptin may increase the hypoglycemic activities of Quinine.
Liraglutide
Liraglutide may increase the hypoglycemic activities of Quinine.
Lisinopril
Quinine may increase the hypotensive activities of Lisinopril.
Lisinopril Anhydrous
Quinine may increase the hypotensive activities of Lisinopril.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Quinine.
Lithium
Lithium may increase the QTc-prolonging activities of Quinine.
Lithium Cation
Lithium may increase the QTc-prolonging activities of Quinine.
Lofexidine
Quinine may increase the hypotensive activities of Lofexidine.
Lomefloxacin
Lomefloxacin may increase the hypoglycemic activities of Quinine.
Lomustine
The metabolism of Lomustine can be decreased when combined with Quinine.
Loperamide
The metabolism of Loperamide can be decreased when combined with Quinine.
Lopinavir
The serum concentration of Quinine can be decreased when it is combined with Lopinavir.
Loratadine
The metabolism of Loratadine can be decreased when combined with Quinine.
Lorcaserin
The metabolism of Lorcaserin can be decreased when combined with Quinine.
Lornoxicam
The metabolism of Lornoxicam can be decreased when combined with Quinine.
Losartan
The metabolism of Quinine can be decreased when combined with Losartan.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Quinine.
Luliconazole
The serum concentration of Quinine can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Quinine can be increased when it is combined with Lumacaftor.
Lumefantrine
The risk or severity of QTc prolongation can be increased when Quinine is combined with Lumefantrine.
Macitentan
Quinine may increase the hypotensive activities of Macitentan.
Magaldrate
The serum concentration of Quinine can be decreased when it is combined with Magaldrate.
Magnesium Carbonate
The serum concentration of Quinine can be decreased when it is combined with Magnesium carbonate.
Magnesium Hydroxide
The serum concentration of Quinine can be decreased when it is combined with Magnesium hydroxide.
Magnesium Oxide
The serum concentration of Quinine can be decreased when it is combined with Magnesium oxide.
Magnesium silicate
The serum concentration of Quinine can be decreased when it is combined with Magnesium silicate.
Magnesium Trisilicate
The serum concentration of Quinine can be decreased when it is combined with Magnesium Trisilicate.
Manidipine
The metabolism of Quinine can be decreased when combined with Manidipine.
Maprotiline
Maprotiline may increase the QTc-prolonging activities of Quinine.
Mecamylamine
Quinine may increase the hypotensive activities of Mecamylamine.
Mecasermin
Quinine may increase the hypoglycemic activities of Mecasermin.
Mecasermin Rinfabate
Quinine may increase the hypoglycemic activities of Mecasermin.
Mefenamic Acid
The metabolism of Mefenamic acid can be decreased when combined with Quinine.
Mefloquine
The risk or severity of adverse effects can be increased when Quinine is combined with Mefloquine.
Melatonin
The metabolism of Melatonin can be decreased when combined with Quinine.
Meloxicam
The metabolism of Meloxicam can be decreased when combined with Quinine.
Meperidine
The metabolism of Pethidine can be decreased when combined with Quinine.
Mephenytoin
The metabolism of Mephenytoin can be decreased when combined with Quinine.
Mequitazine
The metabolism of Mequitazine can be decreased when combined with Quinine.
Mesalamine
Mesalazine may increase the hypoglycemic activities of Quinine.
Mesoridazine
The serum concentration of Mesoridazine can be increased when it is combined with Quinine.
Mesterolone
Mesterolone may increase the hypoglycemic activities of Quinine.
Mestranol
The metabolism of Mestranol can be decreased when combined with Quinine.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Quinine.
Metformin
Metformin may increase the hypoglycemic activities of Quinine.
Methadone
Methadone may increase the QTc-prolonging activities of Quinine.
Methamphetamine
The metabolism of Methamphetamine can be decreased when combined with Quinine.
Methotrimeprazine
The metabolism of Quinine can be decreased when combined with Methotrimeprazine.
Methoxyflurane
The metabolism of Methoxyflurane can be decreased when combined with Quinine.
Methyl Salicylate
Methyl salicylate may increase the hypoglycemic activities of Quinine.
Methyldopa
Quinine may increase the hypotensive activities of Methyldopa.
METHYLDOPA ANHYDROUS
Quinine may increase the hypotensive activities of Methyldopa.
Methylene blue
The serum concentration of Methylene blue can be increased when it is combined with Quinine.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Quinine.
Methylphenidate
The metabolism of Methylphenidate can be decreased when combined with Quinine.
Methyltestosterone
Methyltestosterone may increase the hypoglycemic activities of Quinine.
Methyprylon
The metabolism of Methyprylon can be decreased when combined with Quinine.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Quinine.
Metipranolol
Quinine may increase the hypotensive activities of Metipranolol.
Metoclopramide
Metoclopramide may increase the QTc-prolonging activities of Quinine.
Metocurine
Quinine may increase the neuromuscular blocking activities of Metocurine.
Metocurine iodide
Quinine may increase the neuromuscular blocking activities of Metocurine Iodide.
Metolazone
Quinine may increase the hypotensive activities of Metolazone.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Quinine.
Metronidazole
Metronidazole may increase the QTc-prolonging activities of Quinine.
Metyrosine
Quinine may increase the hypotensive activities of Metyrosine.
Mexiletine
The metabolism of Quinine can be decreased when combined with Mexiletine.
Mianserin
The metabolism of Mianserin can be decreased when combined with Quinine.
Mibefradil
Quinine may increase the hypotensive activities of Mibefradil.
Midostaurin
The metabolism of Quinine can be decreased when combined with Midostaurin.
Mifepristone
Quinine may increase the QTc-prolonging activities of Mifepristone.
Miglitol
Miglitol may increase the hypoglycemic activities of Quinine.
Miglustat
Miglustat may increase the hypoglycemic activities of Quinine.
Milnacipran
Milnacipran may increase the hypoglycemic activities of Quinine.
Minaprine
The metabolism of Minaprine can be decreased when combined with Quinine.
Minoxidil
Quinine may increase the hypotensive activities of Minoxidil.
Mirabegron
Mirabegron may increase the QTc-prolonging activities of Quinine.
Mirtazapine
Mirtazapine may increase the QTc-prolonging activities of Quinine.
Mitotane
The serum concentration of Quinine can be decreased when it is combined with Mitotane.
Mivacurium
Quinine may increase the neuromuscular blocking activities of Mivacurium.
Moclobemide
The metabolism of Moclobemide can be decreased when combined with Quinine.
Modafinil
The metabolism of Quinine can be decreased when combined with Modafinil.
Moexipril
Moexipril may increase the QTc-prolonging activities of Quinine.
Montelukast
The metabolism of Montelukast can be decreased when combined with Quinine.
Moricizine
The serum concentration of Moricizine can be increased when it is combined with Quinine.
Morphine
The metabolism of Morphine can be decreased when combined with Quinine.
Moxifloxacin
Moxifloxacin may increase the QTc-prolonging activities of Quinine.
Moxonidine
Quinine may increase the hypotensive activities of Moxonidine.
Mycophenolate Mofetil
The metabolism of Mycophenolate mofetil can be decreased when combined with Quinine.
Nabilone
The metabolism of Quinine can be decreased when combined with Nabilone.
Nadolol
Quinine may increase the hypotensive activities of Nadolol.
Nalidixic Acid
Nalidixic Acid may increase the hypoglycemic activities of Quinine.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Quinine.
Naloxone
The metabolism of Naloxone can be decreased when combined with Quinine.
Nandrolone
Nandrolone may increase the hypoglycemic activities of Quinine.
Nandrolone Decanoate
Nandrolone decanoate may increase the hypoglycemic activities of Quinine.
Naproxen
The metabolism of Naproxen can be decreased when combined with Quinine.
Nateglinide
The metabolism of Nateglinide can be decreased when combined with Quinine.
Nebivolol
The serum concentration of Nebivolol can be increased when it is combined with Quinine.
Nefazodone
The metabolism of Quinine can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Quinine can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Quinine can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Quinine can be increased when combined with Nevirapine.
Nialamide
Nialamide may increase the hypoglycemic activities of Quinine.
Nicardipine
The metabolism of Quinine can be decreased when combined with Nicardipine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Quinine.
Niclosamide
The metabolism of Niclosamide can be decreased when combined with Quinine.
Nicorandil
Quinine may increase the hypotensive activities of Nicorandil.
Nicotine
The metabolism of Nicotine can be decreased when combined with Quinine.
Nicotine Polacrilex
The metabolism of Nicotine can be decreased when combined with Quinine.
Nifedipine
The metabolism of Nifedipine can be decreased when combined with Quinine.
Nilotinib
The risk or severity of QTc prolongation can be increased when Quinine is combined with Nilotinib.
Nilvadipine
Quinine may increase the hypotensive activities of Nilvadipine.
Nimodipine
Quinine may increase the hypotensive activities of Nimodipine.
Nintedanib
The serum concentration of Nintedanib can be increased when it is combined with Quinine.
Nisoldipine
Quinine may increase the hypotensive activities of Nisoldipine.
Nitrendipine
Quinine may increase the hypotensive activities of Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Quinine.
Nitrofurazone
The metabolism of Nitrofural can be decreased when combined with Quinine.
Nitroprusside
Quinine may increase the hypotensive activities of Nitroprusside.
Norfloxacin
Norfloxacin may increase the QTc-prolonging activities of Quinine.
Nortriptyline
Nortriptyline may increase the QTc-prolonging activities of Quinine.
Octreotide
Octreotide may increase the QTc-prolonging activities of Quinine.
Ofloxacin
Ofloxacin may increase the QTc-prolonging activities of Quinine.
Olanzapine
Olanzapine may increase the QTc-prolonging activities of Quinine.
Olaparib
The metabolism of Quinine can be decreased when combined with Olaparib.
Olmesartan
Quinine may increase the hypotensive activities of Olmesartan.
Olodaterol
Olodaterol may increase the QTc-prolonging activities of Quinine.
Olsalazine
Olsalazine may increase the hypoglycemic activities of Quinine.
Ombitasvir
The metabolism of Ombitasvir can be decreased when combined with Quinine.
Omeprazole
The metabolism of Quinine can be decreased when combined with Omeprazole.
Ondansetron
Ondansetron may increase the QTc-prolonging activities of Quinine.
Opium
The metabolism of Opium can be decreased when combined with Quinine.
Osimertinib
The serum concentration of Quinine can be increased when it is combined with Osimertinib.
Ospemifene
The metabolism of Ospemifene can be decreased when combined with Quinine.
Oxandrolone
Oxandrolone may increase the hypoglycemic activities of Quinine.
Oxaprozin
The metabolism of Oxaprozin can be decreased when combined with Quinine.
Oxprenolol
Quinine may increase the hypotensive activities of Oxprenolol.
Oxycodone
The metabolism of Oxycodone can be decreased when combined with Quinine.
Oxymetholone
Oxymetholone may increase the hypoglycemic activities of Quinine.
Oxymorphone
The metabolism of Oxymorphone can be decreased when combined with Quinine.
Oxytocin
Oxytocin may increase the QTc-prolonging activities of Quinine.
Paclitaxel
The metabolism of Paclitaxel can be decreased when combined with Quinine.
Palbociclib
The serum concentration of Quinine can be increased when it is combined with Palbociclib.
Paliperidone
The risk or severity of QTc prolongation can be increased when Quinine is combined with Paliperidone.
Palonosetron
The metabolism of Palonosetron can be decreased when combined with Quinine.
Pancuronium
Quinine may increase the neuromuscular blocking activities of Pancuronium.
Pancuronium Bromide
Quinine may increase the neuromuscular blocking activities of Pancuronium.
Panobinostat
The serum concentration of Quinine can be increased when it is combined with Panobinostat.
Pantoprazole
The metabolism of Quinine can be decreased when combined with Pantoprazole.
Paramethadione
The metabolism of Paramethadione can be decreased when combined with Quinine.
Parecoxib
The metabolism of Parecoxib can be decreased when combined with Quinine.
Paregoric
The metabolism of Morphine can be decreased when combined with Quinine.
Pargyline
Quinine may increase the hypotensive activities of Pargyline.
Paroxetine
The metabolism of Quinine can be decreased when combined with Paroxetine.
Pasireotide
Pasireotide may increase the QTc-prolonging activities of Quinine.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Quinine.
Pefloxacin
Pefloxacin may increase the hypoglycemic activities of Quinine.
Peginterferon Alfa-2b
The serum concentration of Quinine can be decreased when it is combined with Peginterferon alfa-2b.
Pegvisomant
Pegvisomant may increase the hypoglycemic activities of Quinine.
Penbutolol
Quinine may increase the hypotensive activities of Penbutolol.
Pentamidine
Pentamidine may increase the QTc-prolonging activities of Quinine.
Pentobarbital
The metabolism of Quinine can be increased when combined with Pentobarbital.
Perazine
The serum concentration of Perazine can be increased when it is combined with Quinine.
Perflutren
Perflutren may increase the QTc-prolonging activities of Quinine.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Quinine.
Perhexiline
The metabolism of Perhexiline can be decreased when combined with Quinine.
Periciazine
The serum concentration of Propericiazine can be increased when it is combined with Quinine.
Perindopril
Quinine may increase the hypotensive activities of Perindopril.
Perphenazine
The serum concentration of Perphenazine can be increased when it is combined with Quinine.
Phenacetin
The metabolism of Phenacetin can be decreased when combined with Quinine.
Phenelzine
Phenelzine may increase the hypoglycemic activities of Quinine.
Phenformin
The metabolism of Phenformin can be decreased when combined with Quinine.
Phenindione
Quinine may increase the anticoagulant activities of Phenindione.
Phenobarbital
The serum concentration of Phenobarbital can be increased when it is combined with Quinine.
Phenoxybenzamine
Quinine may increase the hypotensive activities of Phenoxybenzamine.
Phenprocoumon
Quinine may increase the anticoagulant activities of Phenprocoumon.
Phentolamine
Quinine may increase the hypotensive activities of Phentolamine.
Phentolamine Mesylate
Quinine may increase the hypotensive activities of Phentolamine.
Phenylbutazone
The metabolism of Phenylbutazone can be decreased when combined with Quinine.
Phenytoin
The serum concentration of Quinine can be decreased when it is combined with Phenytoin.
Pimozide
The risk or severity of QTc prolongation can be increased when Quinine is combined with Pimozide.
Pinacidil
Quinine may increase the hypotensive activities of Pinacidil.
Pindolol
The metabolism of Pindolol can be decreased when combined with Quinine.
Pioglitazone
The metabolism of Pioglitazone can be decreased when combined with Quinine.
Pipecuronium
Quinine may increase the neuromuscular blocking activities of Pipecuronium.
Piperazine
The metabolism of Piperazine can be decreased when combined with Quinine.
Pipothiazine
The metabolism of Pipotiazine can be decreased when combined with Quinine.
Piroxicam
The metabolism of Piroxicam can be decreased when combined with Quinine.
Piroxicam-Beta-Cyclodextrin
The metabolism of Piroxicam can be decreased when combined with Quinine.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Quinine.
Polythiazide
Quinine may increase the hypotensive activities of Polythiazide.
Ponatinib
The metabolism of Ponatinib can be decreased when combined with Quinine.
Posaconazole
The metabolism of Quinine can be decreased when combined with Posaconazole.
Pramlintide
Pramlintide may increase the hypoglycemic activities of Quinine.
Prasugrel
The metabolism of Prasugrel can be decreased when combined with Quinine.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Quinine.
Prazosin
Quinine may increase the hypotensive activities of Prazosin.
Prilocaine
The risk or severity of adverse effects can be increased when Quinine is combined with Prilocaine.
Primaquine
Primaquine may increase the QTc-prolonging activities of Quinine.
Primidone
The metabolism of Quinine can be increased when combined with Primidone.
Procainamide
The risk or severity of QTc prolongation can be increased when Quinine is combined with Procainamide.
Procaine
Procaine may increase the hypoglycemic activities of Quinine.
Procarbazine
Procarbazine may increase the hypoglycemic activities of Quinine.
Prochlorperazine
The serum concentration of Prochlorperazine can be increased when it is combined with Quinine.
Progesterone
The metabolism of Progesterone can be decreased when combined with Quinine.
Proguanil
The metabolism of Proguanil can be decreased when combined with Quinine.
Promazine
Promazine may increase the QTc-prolonging activities of Quinine.
Promethazine
Promethazine may increase the QTc-prolonging activities of Quinine.
Propafenone
The serum concentration of Quinine can be increased when it is combined with Propafenone.
Propofol
Propofol may increase the QTc-prolonging activities of Quinine.
Propranolol
The metabolism of Propranolol can be decreased when combined with Quinine.
Protriptyline
Protriptyline may increase the QTc-prolonging activities of Quinine.
Pseudoephedrine
The metabolism of Pseudoephedrine can be decreased when combined with Quinine.
Pyrantel
Quinine may increase the neuromuscular blocking activities of Pyrantel.
Pyrimethamine
The metabolism of Quinine can be decreased when combined with Pyrimethamine.
Quazepam
The metabolism of Quazepam can be decreased when combined with Quinine.
Quetiapine
The risk or severity of QTc prolongation can be increased when Quinine is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of QTc prolongation can be increased when Quinine is combined with Quetiapine.
Quinapril
Quinine may increase the hypotensive activities of Quinapril.
Quinidine
The risk or severity of QTc prolongation can be increased when Quinine is combined with Quinidine.
Rabeprazole
The metabolism of Quinine can be decreased when combined with Rabeprazole.
Ramipril
Quinine may increase the hypotensive activities of Ramipril.
Ranitidine
The metabolism of Ranitidine can be decreased when combined with Quinine.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Quinine.
Rapacuronium
Quinine may increase the neuromuscular blocking activities of Rapacuronium.
Rasagiline
Rasagiline may increase the hypoglycemic activities of Quinine.
Regular Insulin, Human
Insulin Human may increase the hypoglycemic activities of Quinine.
Remoxipride
The metabolism of Remoxipride can be decreased when combined with Quinine.
Repaglinide
The metabolism of Repaglinide can be decreased when combined with Quinine.
Rescinnamine
Quinine may increase the hypotensive activities of Rescinnamine.
Reserpine
Quinine may increase the hypotensive activities of Reserpine.
Rifabutin
The metabolism of Quinine can be increased when combined with Rifabutin.
Rifampin
The serum concentration of Quinine can be decreased when it is combined with Rifampicin.
Rifapentine
The metabolism of Quinine can be increased when combined with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Quinine.
Rilmenidine
Quinine may increase the hypotensive activities of Rilmenidine.
Rilpivirine
The serum concentration of Rilpivirine can be decreased when it is combined with Quinine.
Riociguat
The metabolism of Riociguat can be decreased when combined with Quinine.
Risperidone
Risperidone may increase the QTc-prolonging activities of Quinine.
Ritonavir
The serum concentration of Quinine can be decreased when it is combined with Ritonavir.
Rocuronium
Quinine may increase the neuromuscular blocking activities of Rocuronium.
Rofecoxib
The metabolism of Rofecoxib can be decreased when combined with Quinine.
Rolapitant
The metabolism of Quinine can be decreased when combined with Rolapitant.
Ropinirole
The metabolism of Quinine can be decreased when combined with Ropinirole.
Ropivacaine
The metabolism of Ropivacaine can be decreased when combined with Quinine.
Rosiglitazone
The metabolism of Rosiglitazone can be decreased when combined with Quinine.
Rosoxacin
Rosoxacin may increase the hypoglycemic activities of Quinine.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Quinine.
Rotigotine
The metabolism of Rotigotine can be decreased when combined with Quinine.
Rucaparib
The metabolism of Rucaparib can be decreased when combined with Quinine.
Salicylic Acid
The metabolism of Salicylic acid can be decreased when combined with Quinine.
Salmeterol
Salmeterol may increase the QTc-prolonging activities of Quinine.
Saquinavir
Saquinavir may increase the QTc-prolonging activities of Quinine.
Saquinavir Mesylate
Saquinavir may increase the QTc-prolonging activities of Quinine.
Sarilumab
The therapeutic efficacy of Quinine can be decreased when used in combination with Sarilumab.
Saxagliptin
The serum concentration of Saxagliptin can be decreased when it is combined with Quinine.
Saxagliptin Anhydrous
The serum concentration of Saxagliptin can be decreased when it is combined with Quinine.
Secobarbital
The metabolism of Quinine can be increased when combined with Secobarbital.
Selegiline
The metabolism of Selegiline can be decreased when combined with Quinine.
Selexipag
The metabolism of Selexipag can be decreased when combined with Quinine.
Sertindole
The metabolism of Sertindole can be decreased when combined with Quinine.
Sertraline
Sertraline may increase the QTc-prolonging activities of Quinine.
Sevoflurane
Sevoflurane may increase the QTc-prolonging activities of Quinine.
Sildenafil
The metabolism of Quinine can be decreased when combined with Sildenafil.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Quinine.
Siltuximab
The serum concentration of Quinine can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Quinine can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Quinine.
Sitagliptin
The metabolism of Sitagliptin can be decreased when combined with Quinine.
Sitagliptin Phosphate
The metabolism of Sitagliptin can be decreased when combined with Quinine.
Sodium Bicarbonate
The serum concentration of Quinine can be decreased when it is combined with Sodium bicarbonate.
Solifenacin
Solifenacin may increase the QTc-prolonging activities of Quinine.
Sorafenib
Sorafenib may increase the QTc-prolonging activities of Quinine.
Sotalol
The risk or severity of QTc prolongation can be increased when Quinine is combined with Sotalol.
Sparfloxacin
Sparfloxacin may increase the hypoglycemic activities of Quinine.
Spirapril
Quinine may increase the hypotensive activities of Spirapril.
ST. JOHN'S WORT EXTRACT
The serum concentration of Quinine can be decreased when it is combined with St. John's Wort.
Stanozolol
Stanozolol may increase the hypoglycemic activities of Quinine.
Succinylcholine
Quinine may increase the neuromuscular blocking activities of Succinylcholine.
Sulfadiazine
The metabolism of Quinine can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
Sulfamethoxazole may increase the QTc-prolonging activities of Quinine.
Sulfamoxole
The metabolism of Sulfamoxole can be decreased when combined with Quinine.
Sulfinpyrazone
The metabolism of Sulfinpyrazone can be decreased when combined with Quinine.
Sulfisoxazole
Sulfisoxazole may increase the QTc-prolonging activities of Quinine.
Sunitinib
Sunitinib may increase the QTc-prolonging activities of Quinine.
Suprofen
The metabolism of Suprofen can be decreased when combined with Quinine.
Talinolol
Quinine may increase the hypotensive activities of Talinolol.
Tamoxifen
The serum concentration of the active metabolites of Tamoxifen can be reduced when Tamoxifen is used in combination with Quinine resulting in a loss in efficacy.
Tamsulosin
The metabolism of Tamsulosin can be decreased when combined with Quinine.
Tapentadol
The metabolism of Tapentadol can be decreased when combined with Quinine.
Tazarotene
The metabolism of Tazarotene can be decreased when combined with Quinine.
Tegaserod
The metabolism of Tegaserod can be decreased when combined with Quinine.
Telaprevir
The metabolism of Quinine can be decreased when combined with Telaprevir.
Telavancin
Telavancin may increase the QTc-prolonging activities of Quinine.
Telithromycin
The serum concentration of Quinine can be increased when it is combined with Telithromycin.
Telmisartan
Quinine may increase the hypotensive activities of Telmisartan.
Temafloxacin
Temafloxacin may increase the hypoglycemic activities of Quinine.
Temazepam
The metabolism of Temazepam can be decreased when combined with Quinine.
Tenofovir Disoproxil
The metabolism of Quinine can be decreased when combined with Tenofovir disoproxil.
Tenoxicam
The metabolism of Tenoxicam can be decreased when combined with Quinine.
Terbinafine
The metabolism of Quinine can be decreased when combined with Terbinafine.
Terbutaline
Terbutaline may increase the QTc-prolonging activities of Quinine.
Terbutaline Sulfate
Terbutaline may increase the QTc-prolonging activities of Quinine.
Terfenadine
The metabolism of Terfenadine can be decreased when combined with Quinine.
Teriflunomide
The serum concentration of Quinine can be decreased when it is combined with Teriflunomide.
Terlipressin
Quinine may increase the hypotensive activities of Terlipressin.
Testosterone
The metabolism of Testosterone can be decreased when combined with Quinine.
Testosterone Cypionate
The metabolism of Testosterone cypionate can be decreased when combined with Quinine.
Testosterone Enanthate
The metabolism of Testosterone enanthate can be decreased when combined with Quinine.
Testosterone Propionate
Testosterone propionate may increase the hypoglycemic activities of Quinine.
Testosterone Undecanoate
The metabolism of Testosterone undecanoate can be decreased when combined with Quinine.
Tetrabenazine
The risk or severity of QTc prolongation can be increased when Quinine is combined with Tetrabenazine.
Tetracycline
The serum concentration of Quinine can be increased when it is combined with Tetracycline.
Tetrahydrocannabinol
The serum concentration of Dronabinol can be increased when it is combined with Quinine.
Thalidomide
The metabolism of Thalidomide can be decreased when combined with Quinine.
Theodrenaline
Quinine may increase the hypotensive activities of Theodrenaline.
Theophylline
The serum concentration of Theophylline can be increased when it is combined with Quinine.
Theophylline anhydrous
The serum concentration of Theophylline can be increased when it is combined with Quinine.
Thiamylal
The metabolism of Thiamylal can be decreased when combined with Quinine.
Thiethylperazine
The serum concentration of Thiethylperazine can be increased when it is combined with Quinine.
Thioproperazine
The serum concentration of Thioproperazine can be increased when it is combined with Quinine.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Quinine.
Thiothixene
Thiothixene may increase the QTc-prolonging activities of Quinine.
Tibolone
Quinine may increase the hypotensive activities of Tibolone.
Ticagrelor
The metabolism of Quinine can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Quinine can be decreased when combined with Ticlopidine.
Timolol
The metabolism of Timolol can be decreased when combined with Quinine.
Timolol Anhydrous
The metabolism of Timolol can be decreased when combined with Quinine.
Tiotropium
The metabolism of Tiotropium can be decreased when combined with Quinine.
Tipranavir
The metabolism of Quinine can be decreased when combined with Tipranavir.
Tizanidine
Tizanidine may increase the QTc-prolonging activities of Quinine.
Tocilizumab
The serum concentration of Quinine can be decreased when it is combined with Tocilizumab.
Tolazamide
Quinine may increase the hypoglycemic activities of Tolazamide.
Tolazoline
Quinine may increase the hypotensive activities of Tolazoline.
Tolbutamide
The metabolism of Quinine can be decreased when combined with Tolbutamide.
Toloxatone
Toloxatone may increase the hypoglycemic activities of Quinine.
Tolterodine
Tolterodine may increase the QTc-prolonging activities of Quinine.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Quinine.
Topiramate
The metabolism of Quinine can be decreased when combined with Topiramate.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Quinine.
Toremifene
The risk or severity of QTc prolongation can be increased when Quinine is combined with Toremifene.
Torsemide
The metabolism of Torasemide can be decreased when combined with Quinine.
Trabectedin
The metabolism of Trabectedin can be decreased when combined with Quinine.
Tramadol
The therapeutic efficacy of Tramadol can be decreased when used in combination with Quinine.
Trandolapril
Quinine may increase the hypotensive activities of Trandolapril.
Tranylcypromine
The metabolism of Quinine can be decreased when combined with Tranylcypromine.
Travoprost
Quinine may increase the hypotensive activities of Travoprost.
Trazodone
Trazodone may increase the QTc-prolonging activities of Quinine.
Treprostinil
Treprostinil may increase the QTc-prolonging activities of Quinine.
Tretinoin
The metabolism of Tretinoin can be decreased when combined with Quinine.
Trichlormethiazide
Quinine may increase the hypotensive activities of Trichlormethiazide.
Trifluoperazine
The serum concentration of Trifluoperazine can be increased when it is combined with Quinine.
Triflupromazine
The serum concentration of Triflupromazine can be increased when it is combined with Quinine.
Trimeprazine
The serum concentration of Alimemazine can be increased when it is combined with Quinine.
Trimethadione
The metabolism of Trimethadione can be decreased when combined with Quinine.
Trimethaphan
Quinine may increase the hypotensive activities of Trimethaphan.
Trimethoprim
Trimethoprim may increase the QTc-prolonging activities of Quinine.
Trimipramine
Trimipramine may increase the QTc-prolonging activities of Quinine.
Triptorelin
Triptorelin may increase the QTc-prolonging activities of Quinine.
Troglitazone
The metabolism of Troglitazone can be decreased when combined with Quinine.
Trolamine Salicylate
Trolamine salicylate may increase the hypoglycemic activities of Quinine.
Tromethamine
The serum concentration of Quinine can be decreased when it is combined with Tromethamine.
Trovafloxacin
Trovafloxacin may increase the hypoglycemic activities of Quinine.
Tubocurarine
Quinine may increase the neuromuscular blocking activities of Tubocurarine.
Umeclidinium
The metabolism of Umeclidinium can be decreased when combined with Quinine.
UNOPROSTONE
Quinine may increase the hypotensive activities of Unoprostone.
Urapidil
Quinine may increase the hypotensive activities of Urapidil.
Valbenazine
The metabolism of Valbenazine can be decreased when combined with Quinine.
Valdecoxib
The metabolism of Valdecoxib can be decreased when combined with Quinine.
Valproate
The metabolism of Valproic Acid can be decreased when combined with Quinine.
Valproic Acid
The metabolism of Valproic Acid can be decreased when combined with Quinine.
Valsartan
The metabolism of Valsartan can be decreased when combined with Quinine.
Vandetanib
The risk or severity of QTc prolongation can be increased when Quinine is combined with Vandetanib.
Vardenafil
Vardenafil may increase the QTc-prolonging activities of Quinine.
Vecuronium
Quinine may increase the neuromuscular blocking activities of Vecuronium.
Velpatasvir
The metabolism of Velpatasvir can be decreased when combined with Quinine.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Quinine.
Venlafaxine
Venlafaxine may increase the QTc-prolonging activities of Quinine.
Verapamil
The metabolism of Quinine can be decreased when combined with Verapamil.
Vilanterol
Vilanterol may increase the QTc-prolonging activities of Quinine.
Vilazodone
The metabolism of Vilazodone can be decreased when combined with Quinine.
Vildagliptin
Vildagliptin may increase the hypoglycemic activities of Quinine.
Vinblastine
The metabolism of Vinblastine can be decreased when combined with Quinine.
Vincamine
Quinine may increase the hypotensive activities of Vincamine.
Vincristine
The excretion of Vincristine can be decreased when combined with Quinine.
Vinorelbine
The metabolism of Vinorelbine can be decreased when combined with Quinine.
Vinpocetine
Quinine may increase the hypotensive activities of Vinpocetine.
Vismodegib
The metabolism of Vismodegib can be decreased when combined with Quinine.
Voriconazole
The metabolism of Quinine can be decreased when combined with Voriconazole.
Vorinostat
Vorinostat may increase the QTc-prolonging activities of Quinine.
Vortioxetine
The metabolism of Vortioxetine can be decreased when combined with Quinine.
Voxilaprevir
The metabolism of Voxilaprevir can be decreased when combined with Quinine.
Warfarin
Quinine may increase the anticoagulant activities of Warfarin.
Xylometazoline
Quinine may increase the hypotensive activities of Xylometazoline.
Yohimbine
The metabolism of Yohimbine can be decreased when combined with Quinine.
Zafirlukast
The metabolism of Quinine can be decreased when combined with Zafirlukast.
Zalcitabine
The metabolism of Zalcitabine can be decreased when combined with Quinine.
Zidovudine
The metabolism of Zidovudine can be decreased when combined with Quinine.
Zileuton
The metabolism of Zileuton can be decreased when combined with Quinine.
Ziprasidone
The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Quinine.
Zofenopril
Quinine may increase the hypotensive activities of Zofenopril.
Zolpidem
The metabolism of Zolpidem can be decreased when combined with Quinine.
Zopiclone
The metabolism of Zopiclone can be decreased when combined with Quinine.
Zuclopenthixol
The risk or severity of QTc prolongation can be increased when Quinine is combined with Zuclopenthixol.
